Mylan found liable for Savella patent infringement

13-07-2016

A US court has sided with Forest Laboratories in a dispute with Mylan Pharmaceuticals centring on the Savella (milnacipran) drug.


Mylan, Forest, Savella, milnacipran, generic, patent, fibromyalgia

LSIPR